118th Congress Health
H.R. 3892: Improving Mental Health and Drug Treatment Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill permanently allows state Medicaid programs to receive federal payment for substance-use disorder services that are provided at institutions for mental diseases (IMDs) for individuals aged 21 to 64. The bill also extends the maximum length of stay over a 12-month period from 30 days to 45 days and requires state Medicaid programs to review IMD compliance with relevant standards of care.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Ritchie Torres D-NYOriginal
- Gus Bilirakis R-FL
- Nicole Malliotakis R-NY
- John James R-MI
Who scored on this bill
- 1Michael Burgess SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Michael Burgess
- H.R. 3284: Providers and Payers COMPETE Act
- H.R. 3884: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
- H.R. 766: Dr. Michael C. Burgess Preventive Health Savings Act
- H.R. 3838: Preventing Maternal Deaths Reauthorization Act of 2023
- H.R. 1115: Promoting Interagency Coordination for Review of Natural Gas Pipelines Act
History
- Introduced in the House by Michael Burgess.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.